论文部分内容阅读
目的:观察平喘汤治疗支气管哮喘(冷哮)急性发作期的临床疗效。方法:将86例支气管哮喘急性发作期患者随机分为对照组和观察组,对照组给予常规西医治疗;观察组在对照组的基础上给予平喘汤治疗。7天为1疗程。观察治疗前后嗜酸性粒细胞(EOS)、Ig E、最大呼气流速(PEF)的改善情况及2组临床疗效。结果:总有效率观察组93.0%,对照组72.0%,2组比较,差异有统计学意义(P<0.05)。2组治疗后EOS、Ig E、PEF均有改善,与本组治疗前比较,差异均有统计学意义(P<0.05);治疗后2组EOS、Ig E、PEF比较,差异均有统计学意义(P<0.05)。结论:平喘汤治疗支气管哮喘(冷哮)急性发作期的临床效果显著,可有效改善患者临床症状,提高患者的生活质量。
Objective: To observe the clinical efficacy of “Pingchuan Decoction” in the treatment of acute exacerbation of bronchial asthma (cold asthma). Methods: Eighty-six patients with acute exacerbation of bronchial asthma were randomly divided into control group and observation group. The control group was given routine Western medical treatment. The observation group was given Pingchuan Decoction on the basis of the control group. 7 days for a course of treatment. The changes of eosinophils (EOS), Ig E and maximum expiratory flow rate (PEF) before and after treatment were observed and the clinical efficacy of the two groups were observed. Results: The total effective rate was 93.0% in observation group and 72.0% in control group, the difference was statistically significant (P <0.05). The EOS, Ig E and PEF in both groups improved after treatment, with statistical significance (P <0.05) compared with those before treatment in both groups. The differences of EOS, Ig E and PEF between the two groups after treatment were statistically significant Significance (P <0.05). Conclusion: The clinical efficacy of Pingchuan Decoction in the treatment of acute exacerbation of bronchial asthma (cold asthma) is significant, which can effectively improve the clinical symptoms and improve the quality of life of patients.